Similar articles

• Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.

  Canafax DM, Simmons RL, Sutherland DE, Fryd DS, Strand MH, Ascher NL, Payne WD, Najarian JS. Canafax DM, et al. Transplant Proc. 1986 Apr;18(2 Suppl 1):192-6. Transplant Proc. 1986. PMID: 3515687 Clinical Trial. No abstract available.
• Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.

  Griño JM, Alsina J, Castelao AM, Sabate I, Mestre M, Gil-Vernet S, Andrés E, Sabater R. Griño JM, et al. Transplant Proc. 1988 Oct;20(5 Suppl 6):18-20. Transplant Proc. 1988. PMID: 3051579 Clinical Trial. No abstract available.
• Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.

  Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O Jr. Feduska NJ, et al. Transplant Proc. 1986 Apr;18(2 Suppl 1):136-40. Transplant Proc. 1986. PMID: 3515681 No abstract available.
• Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?

  Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM. Posner MP, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1594-7. Transplant Proc. 1989. PMID: 2652519 Clinical Trial. No abstract available.
• Steps in immunosuppression for renal transplantation.

  Starzl TE, Rosenthal JT, Hakala TR, Iwatsuki S, Shaw BW Jr, Klintmalm GB. Starzl TE, et al. Kidney Int Suppl. 1983 May;(14):S-60-5. Kidney Int Suppl. 1983. PMID: 6348374 Free PMC article. Review. No abstract available.